Happy Friday! The ESACT - European Society for Animal Cell Technology Congress is just around the corner now. Come see our CSO, Markus Hörer discussing "Transitioning Advanced Therapies from Research to Development and #Manufacturing - What Have We Learned About Developability?" with Boehringer Ingelheim on Sunday, June 23 at 1:00. Can't make it to the talk? No worries! We're always accessible to chat #genetherapy via DM or business@ascend-adv.com.
Ascend Advanced Therapies’ Post
More Relevant Posts
-
President-Pistoia Alliance | Bringing Lifescience and Pharma organisations together to collaborate |
Join us in January for this webinar "Advancing Research: Reducing Animal Models in Experiments." This event will address the urgent need to decrease the reliance on animal models in scientific research, particularly in light of the FDA Modernization Act 2.0. The webinar will provide an overview of the current research environment and explore innovative alternatives such as virtual control groups, organ-on-a-chip technology, and in-vitro methods. The agenda will cover topics including the validation of alternative approaches. Don't miss this opportunity to learn more and engage in the poll and Q&A sessions. #scientificresearch #animalmodelalternatives https://buff.ly/3SJkGyk
-
🐾🩺 Webinar Spotlight: "Syncope - The descent to death" 🩺🐾 Join us for a riveting webinar as we delve into the critical topic of syncope in small animal patients. Emily, our esteemed speaker, will guide you through the complexities of episodic collapse, shedding light on why the presence of syncope can be a poor prognostic indicator, sometimes leading to tragic outcomes. To watch on-demand, click here https://bit.ly/3tBR8Zd
-
-
Check out our latest blog post featuring an excellent review of Large Animal models for studying HFpEF (Heart Failure with preserved Ejection Fraction) using clinical score systems. #HFpEF #HeartFailure https://hubs.ly/Q02v82PD0
-
Last chance today to talk with Dr. Luo!
Senior Director of Business Development, Pharmalegacy Laboratories; Principal Consultant, SymBio Services, LLC
Over 100 people squeezed in to listen to Dr. Chang Luo’s presentation on animal models of Wet and Dry AMD and Subretinal Fibrosis at ARVO yesterday! If you didn’t get a chance to talk to Dr. Luo, stop by our booth #4703 today 😎
-
-
Helps companies connect to strategic solutions in their drug development efforts. Detail oriented. Proactive. Responsive.
SAVE THE DATE! Exciting news for those interested in alternative large animal models! Join us for a one-day scientific conference to discuss minipig care, handling, and use in biomedical research. Register now: https://lnkd.in/dcibBeg9 #ScientificConference #MinipigResearch #BiomedicalResearch #AnimalModels
-
-
✨Exciting news!✨ We're part-funding the brilliant #XCellR8 to develop another animal-free replacement test! This time our focus is the inhalation toxicity tests (LC50), which are cruel and scientifically irrelevant. The new, animal-free test will be safer for humans, kinder to animals 🩷 Keep an eye on our feed to learn more 🧫🧪🔬 #BetterScience #SaferScience #AnimalFreeScience #ToxicityTests #LC50 #EndAnimalTesting
-
-
Scientists at EARA Member the University of Zurich, Switzerland, have developed a new method of giving drugs to mice for research studies, that greatly reduces animal stress. While it is effective, the traditional drug delivery method in mice – an oral gavage which puts a metal tube into the mouth – can cause stress and tissue damage. The new method trains mice to drink a solution of diluted condensed milk containing the required drug on a pipette, which they are happy to take voluntarily. Called Micropipette-Guided Drug Administration (MDA), it provides a more humane and efficient alternative, improves animal welfare, and should therefore lead to better research results. Read more: https://lnkd.in/e2HJ7iGx #AnimalResearch #3Rs #AnimalWelfare #Mice #DrugTesting
Reducing stress in mice in drug testing
eara.eu
-
May 19, 1987, marked a pivotal moment in medical innovation with Chet Fleming's patent for providing support to an animal's severed head. Tested extensively on research animals, this breakthrough offers potential applications for humans facing terminal illnesses. At IPr Solution, we recognize the profound impact of such groundbreaking inventions and are dedicated to supporting innovators like Chet Fleming in bringing their ideas to fruition. Let's honor the spirit of ingenuity and progress, shaping a future where medical boundaries are continually pushed. 👉Visit us: www.4aipsolution.in 📩contact@4aipsolution.in 👉Follow us on: https://lnkd.in/enCeJBi3 https://lnkd.in/eKyRDCvg https://lnkd.in/gdzyc5_M . . #MedicalInnovation #GroundbreakingInvention #PatentHistory #ChetFleming #ResearchBreakthrough #MedicalAdvancements #InnovativeIdeas #IPProtection #SupportingInnovators #FutureOfMedicine #TerminalIllnessSupport #MedicalResearch #InnovationInMedicine #IPRSolution #PioneeringScience
-
-
The shift from using test animals to applying the 'Weight of Evidence' approach is a significant transition in Non-Clinical Research. This transition highlights ethical considerations, leveraging diverse data sources to make informed decisions without animal testing, ultimately reducing the number of test animals needed in drug development while increasing predictivity. We will discuss this topic (a.o.) in our upcoming webinar on Challenges in Non-Clinical Drug Development with our experts André Wolterbeek and Arthur Noach. Secure you're spot and register today! https://lnkd.in/dfzQXP3d #nonclinical #drugdevelopment #lifesciences #animalfree
-
-
We’re giving you the top five benefits (F.A.C.T.S.) of choosing Mispro for your preclinical studies. Benefit #1 Focus: We remove the barriers of running a vivarium and managing animal care and compliance so you can stay focused on your preclinical studies. Spend your time discovering while we manage the rest. Learn more https://buff.ly/3wflkua #contractvivarium #preclinical #focus
